Bocaliner

DEVICE2 trials

Sponsors

E2Bio Life Sciences, LLC

Conditions

Oral MucositisStem Cell Transplant Complications

Early Phase 1

Study of a New Medical Device for Oral Mucositis

WithdrawnNCT05104268

E2Bio Life Sciences, LLCOral Mucositis, Stem Cell Transplant Complications

Start: 2024-11-30End: 2025-12-31Updated: 2026-09-11

Phase 1

Study for the Prevention of Oral Mucositis (SPOM)

E2Bio Life Sciences, LLCOral Mucositis

Start: 2022-04-15End: 2023-12-31Target: 100Updated: 2023-09-08

Related Papers

Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapy.

2025-07-311 citations

Study for the prevention of oral mucositis.

Journal of Clinical Oncology2023-06-01